Sabra Healthcare REIT (NASDAQ:SBRA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

Sabra Healthcare REIT, Inc. (NASDAQ:SBRAGet Free Report)’s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $20.15 and traded as high as $20.82. Sabra Healthcare REIT shares last traded at $20.61, with a volume of 1,607,209 shares trading hands.

Analyst Ratings Changes

Several research firms have weighed in on SBRA. Citizens Jmp boosted their price target on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research note on Wednesday, July 22nd. Raymond James Financial upgraded Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Cantor Fitzgerald upped their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Finally, Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Seven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $22.27.

Read Our Latest Stock Report on SBRA

Sabra Healthcare REIT Trading Down 0.4%

The stock has a market cap of $5.27 billion, a PE ratio of 79.27, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The company’s 50-day moving average price is $20.43 and its 200 day moving average price is $20.15. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last issued its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The business had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The company’s revenue was up 24.7% on a year-over-year basis. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.8%. The ex-dividend date is Friday, August 14th. Sabra Healthcare REIT’s payout ratio is 461.54%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Focus Partners Wealth raised its stake in shares of Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after acquiring an additional 2,375 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the last quarter. First Trust Advisors LP increased its holdings in Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock valued at $6,793,000 after purchasing an additional 78,709 shares during the last quarter. Cerity Partners LLC raised its position in Sabra Healthcare REIT by 73.0% in the second quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after purchasing an additional 7,885 shares during the period. Finally, Daiwa Securities Group Inc. lifted its stake in Sabra Healthcare REIT by 3.1% during the second quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock worth $1,547,000 after purchasing an additional 2,557 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Further Reading

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.